Concepedia
Statistics
Publications
90
Citations
10.6K
H-Index
51
Active since
1982
Affiliations
AstraZeneca (Sweden)(Current)
Sahlgrenska University Hospital
Bayreuth Medical Center
Otto-von-Guericke University Magdeburg
Charité - Universitätsmedizin Berlin
Tore Lind is an author at AstraZeneca (Sweden) specializing in medicine, gastroenterology, and anesthesiology.
Top concepts
MedicineGastroenterologyPharmacologyAnesthesiologyPharmacotherapyGastrointestinal PharmacologySurgeryPhysiologyEmergency MedicineClinical Pharmacology
Publications per year
1982–2017
Development of the GerdQ, a tool for the diagnosis and management of gastro‐oesophageal reflux disease in primary care
Roderick C. Jones, Ola Junghard, John Dent et al. · Alimentary Pharmacology & Therapeutics · 2009 · 678 citations
Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
Tore Lind, Sander Veldhuyzen van Zanten, Peter Unge et al. · Helicobacter · 1996 · 575 citations
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
Tore Lind, C. Cederberg, Gunnar Ekenved et al. · Gut · 1983 · 503 citations · Full text
Molecular Pharmacology, Healthy Subjects, Gastrointestinal Pharmacology +9
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report
Jukka Ronkainen, Pertti Aro, Tom Storskrubb et al. · Scandinavian Journal of Gastroenterology · 2005 · 464 citations
The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
Tore Lind, Françis Mégraud, Peter Unge et al. · Gastroenterology · 1999 · 431 citations
Medicine, Gastroenterology, 1-Week Triple Therapies +2
Rows per page
1–5 of 90